GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Enzo Biochem Inc (NYSE:ENZ) » Definitions » Shiller PE Ratio

Enzo Biochem (Enzo Biochem) Shiller PE Ratio : 105.00 (As of Apr. 29, 2024)


View and export this data going back to 1980. Start your Free Trial

What is Enzo Biochem Shiller PE Ratio?

As of today (2024-04-29), Enzo Biochem's current share price is $1.05. Enzo Biochem's E10 for the quarter that ended in Jan. 2024 was $0.01. Enzo Biochem's Shiller PE Ratio for today is 105.00.

The historical rank and industry rank for Enzo Biochem's Shiller PE Ratio or its related term are showing as below:

ENZ' s Shiller PE Ratio Range Over the Past 10 Years
Min: 105   Med: 136.5   Max: 162
Current: 112.88

During the past years, Enzo Biochem's highest Shiller PE Ratio was 162.00. The lowest was 105.00. And the median was 136.50.

ENZ's Shiller PE Ratio is ranked worse than
89.74% of 78 companies
in the Medical Diagnostics & Research industry
Industry Median: 27.245 vs ENZ: 112.88

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Enzo Biochem's adjusted earnings per share data for the three months ended in Jan. 2024 was $-0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.01 for the trailing ten years ended in Jan. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Enzo Biochem Shiller PE Ratio Historical Data

The historical data trend for Enzo Biochem's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzo Biochem Shiller PE Ratio Chart

Enzo Biochem Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 204.37

Enzo Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 204.37 381.72 135.45

Competitive Comparison of Enzo Biochem's Shiller PE Ratio

For the Diagnostics & Research subindustry, Enzo Biochem's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enzo Biochem's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Enzo Biochem's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Enzo Biochem's Shiller PE Ratio falls into.



Enzo Biochem Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Enzo Biochem's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=1.05/0.01
=105.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enzo Biochem's E10 for the quarter that ended in Jan. 2024 is calculated as:

For example, Enzo Biochem's adjusted earnings per share data for the three months ended in Jan. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jan. 2024 (Change)*Current CPI (Jan. 2024)
=-0.06/129.4194*129.4194
=-0.060

Current CPI (Jan. 2024) = 129.4194.

Enzo Biochem Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201404 -0.010 100.023 -0.013
201407 -0.070 100.520 -0.090
201410 -0.080 100.176 -0.103
201501 -0.090 98.604 -0.118
201504 -0.060 99.824 -0.078
201507 0.190 100.691 0.244
201510 0.100 100.346 0.129
201601 0.150 99.957 0.194
201604 -0.050 100.947 -0.064
201607 0.770 101.524 0.982
201610 -0.030 101.988 -0.038
201701 -0.020 102.456 -0.025
201704 -0.002 103.167 -0.003
201707 0.002 103.278 0.003
201710 -0.010 104.070 -0.012
201801 -0.020 104.578 -0.025
201804 -0.060 105.708 -0.073
201807 -0.120 106.324 -0.146
201810 -0.130 106.695 -0.158
201901 -0.180 106.200 -0.219
201904 0.470 107.818 0.564
201907 -0.110 108.250 -0.132
201910 -0.160 108.577 -0.191
202001 -0.160 108.841 -0.190
202004 -0.210 108.173 -0.251
202007 -0.070 109.318 -0.083
202010 0.010 109.861 0.012
202101 0.050 110.364 0.059
202104 0.040 112.673 0.046
202107 0.060 115.183 0.067
202110 -0.050 116.696 -0.055
202201 -0.050 118.619 -0.055
202204 -0.100 121.978 -0.106
202207 -0.180 125.002 -0.186
202210 -0.220 125.734 -0.226
202301 -0.230 126.223 -0.236
202304 -0.310 127.992 -0.313
202307 1.170 128.974 1.174
202310 -0.130 129.810 -0.130
202401 -0.060 129.419 -0.060

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Enzo Biochem  (NYSE:ENZ) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Enzo Biochem Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Enzo Biochem's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzo Biochem (Enzo Biochem) Business Description

Traded in Other Exchanges
Address
527 Madison Avenue, New York, NY, USA, 10022
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.
Executives
Steven J Pully director 9800 RICHMOND AVE, SUITE 700, HOUSTON TX 77042
James G. Wolf 10 percent owner 105, FLYWAY DRIVE, KIAWAH ISLAND SC 29455
Hamid Erfanian officer: Chief Executive Officer 527 MADISON AVENUE, NEW YORK NY 10022
Patricia Eckert officer: Interim CFO C/O ENZO BIOCHEM, INC., 81 EXECUTIVE BLVD, SUITE 3, FARMINGDALE NY 11735
Kara Cannon officer: Chief Operating Officer 527 MADISON AVE, NEW YORK NY 10022
Bradley Louis Radoff director 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098
David Bench officer: CHIEF FINANCIAL OFFICER ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Harbert Discovery Fund, Lp 10 percent owner HARBERT DISCOVERY FUND GP, LLC, 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203
Ian B. Walters director ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Mary Tagliaferri director 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO CA 94158
Clemens Peter J Iv 10 percent owner 2383 N. BERRY'S CHAPEL RD., FRANKLIN TN 37069
Rebecca J. Fischer director ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK NY 10022
Fabian Blank 10 percent owner, other: See Remarks ROEMERSTRASSE 6, BAD BERTRICH 2M 56864
Harbert Management Corp 10 percent owner 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203
Harbert Discovery Co-investment Fund I Gp, Llc 10 percent owner 2100 THIRD AVENUE NORTH, SUITE 600, BIRMINGHAM AL 35203